Citation: A. Mcdougal et al., Tamoxifen-induced antitumorigenic/antiestrogenic action synergized by a selective aryl hydrocarbon receptor modulator, CANCER RES, 61(10), 2001, pp. 3902-3907
Citation: S. Safe et al., Mechanisms of inhibitory aryl hydrocarbon receptor-estrogen receptor crosstalk in human breast cancer cells, J MAMMARY G, 5(3), 2000, pp. 295-306
Authors:
Wormke, M
Castro-Rivera, E
Chen, I
Safe, S
Citation: M. Wormke et al., Estrogen and aryl hydrocarbon receptor expression and crosstalk in human Ishikawa endometrial cancer cells, J STEROID B, 72(5), 2000, pp. 197-207
Authors:
Saville, B
Wormke, M
Wang, F
Nguyen, T
Enmark, E
Kuiper, G
Gustafsson, JA
Safe, S
Citation: B. Saville et al., Ligand-, cell-, and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Sp1) promoter elements, J BIOL CHEM, 275(8), 2000, pp. 5379-5387
Authors:
Stoner, M
Wang, F
Wormke, M
Nguyen, T
Samudio, I
Vyhlidal, C
Marme, D
Finkenzeller, G
Safe, S
Citation: M. Stoner et al., Inhibition of vascular endothelial growth factor expression in HEC1A endometrial cancer cells through interactions of estrogen receptor alpha and Sp3proteins, J BIOL CHEM, 275(30), 2000, pp. 22769-22779
Citation: M. Wormke et al., Crosstalk between estrogen receptor alpha and the aryl hydrocarbon receptor in breast cancer cells involves unidirectional activation of proteasomes, FEBS LETTER, 478(1-2), 2000, pp. 109-112
Citation: E. Castro-rivera et al., Estrogen and aryl hydrocarbon responsiveness of ECC-1 endometrial cancer cells, MOL C ENDOC, 150(1-2), 1999, pp. 11-21